Selected Publications Emerging Oncology Biomarkers.Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab. Molecular Oncology, 2023.A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. The Oncologist, 2023. Hepatitis B.No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrobial Agents and Chemotherapies, 2018.Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients. Scientific Reports, 2019.Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon version. Journal of Viral Hepatitis, 2021. Hepatitis C.Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. Journal of Hepatology, 2017.Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens. Journal of Viral Hepatology, 2018. Endogenous Retroviruses.Endogenous retroviruses and human cancer: is there anything to the rumors? Cell Host Microbe, 2014.HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. Journal of Virology, 2014.
